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I N ADDITION to immunosuppression. complex and for the most part similar metabolic effects are caused by 
cyclosporine (CyA) and FK 506. even though these drugs 
are chemically unrelated and have different cytosolic bind-
ing sites (called immunophilins) (Table I). One of the 
striking nonimmunological effects of Cy A and FK S06 is 
hepatocyte proliferation. which can be demonstrated in the 
in vivo models shown in Table 2. I~ but not in hepatocyte 
cultures. 7 
In this report. we will emphasize some in vivo and in 
vitro experiments with another drug. rapamycin (RPM). 
which is chemically related to FK 506 and has the same 
binding site (called FK-binding protein or FKBP).1.91t was 
found that RPM has hepatocyte growth effects opposite to 
Cy A and FK 506. 
PARTIAL HEPATECTOMY EXPERIMENTS 
Makowka et all first demonstrated that 4 days of treatment 
with CyA at an oral dose of 10 mw'kg per day increases 
hepatocyte proliferation in rats then submitted to 70% 
partial hepatectomy (PH). The same stimulatory effect was 
found with 4 days of FK 506 given intramuscularly at the 
dose of I mglkg (Fig 1).4 The effect was liver specific (Fig 
2) in that FK 506 administration did not alter the regener-
ation response of remaining small intestine after 40% 
resection. or that of the remaining kidney after unilateral 
nephrectomy. 
At first. it was suspected that the foregoing results 
reftected immune modulation of regeneration which had 
been perturbed (augmented) by T -ceU-specific immuno-
suppression. This hypothesis was tested by repeating the 
experiments in T -celkieficient nude rats. '0 The results 
were the same as normal animals (Fig 3) and suggested that 
the augmentation of regeneration was by a nonimmuno-
logic mechanism. 
In contrast to the augmentation of liver regeneration 
caused by 4 days of pretreatment with Cy A or FK 506. the 
administration of rapamycin in the 70% PH rat model 
Table 1. Etlecta of CyA and FK 508 
Inhibition 01 T -lymphocyte 
pralferatton and activation 
NeptvoIOXICIIy 
0iabeIIIa 
Hair growth 
Hypen:tIclal.roIemia 
Modulation of hepebc size and 
proIifetmiol, 
In vitro: 
In vivo: 
TUIe 2. Method. 
Primary hepatocyte cultures.T ••• 
Seventy percent partial hepatectomy (PH) in rats (pre-
operative administration of the drugs (for 4 days] 
followed by 70% PH + another administration. Sac· 
rifice 24 hours later). , .... 
Portacaval shunt (PCS) in dogs (sacrifice after a 4-day 
continuous infusion of the drug in the lett portal 
vain}. U. '2.'3 
induces a strong and dose-related inhibition of hepatocyte 
proliferation (Fig 4)." RPM also inhibited DNA synthesis 
in the remaining small intestine after 40% resection. and in 
the remaining kidney after unilateral nephrectomy (Fig 
2). " 
THE ECK FISTULA 
The other in vivo model was in dogs. who underwent a 
functional end-la-side portacaval shunt (PCS) (Table 2). 
For 4 days after the shunt. drugs were continuously 
infused through an external pump into the detached left 
branch of the portal vein (Fig RFKD~ Hepatocyte size and 
organelle structure were quantitated and proliferation was 
estimated by nuclear thymidine incorporation (classical 
autoradiography). These parameters were compared in the 
left (treated) versus the right (untreated) lobes. Both CyA 
(not shown) and FK 506 (Table 3) greatly increased the 
rate of hepatocyte replication. '.6 They also prevented the 
acute hepatocyte atrophy and disruption of organelles 
which are caused by portacaval shunt.'-6 In addition. it 
was demonstrated that infusion of recombinant FKBP in 
drug-free Eck fistula animals also had these same "hepa-
totrophic" effects of proliferation and maintenance of 
hepatocyte size and organelle integrity (Table 4).13 
RPM infused into the left portal branch had none of the 
From the Depanment of Surgery. University Health Center of 
Pittsburgh. Pittsburgh. Pennsytvania (T.E.S .• B.C .. A.A .• G.C .. 
a.H.z .• K.A.P.) and the Department of Gastroenterology. Univer-
sity of Sari. Bari. Italy (A.F.). 
Supported by research grants from the Veterans Administration 
and Project Grant Nos. OK 29961 and CA 44602 from the National 
InstituteS of Health. Bethesda. Maryland. 
Address reprint requests to Thomas E. Starzi. MD. PhD. De-
partment of Surgery. 3601 Fifth Avenue. 5C Fafk Clinic. University 
of PIttsburgh. Pittsburgh. PA 15213. 
C 1991 by Appleton & Lange 
0041-13451911$3.001+ 0 
T/W'IIpWIta/lDn mt~ Voj 23. No 8 (December). 1991: pp 2817-2820 2817 
2818 
c 
o eo 
50 
.. 0 ~ 
30 ~ 
-o 
20 ~ 
to 
+ 
fig 1. fH]thymidine inc:orllOration and percentage of mitosis in 
normal and 70% hepat8CtOmized rats treated or not treated with 
FK 506 and CyA. The animals were given oral CyA and intramus-
cular FK 506 at 10 mgt1cg and 1 mgIkg body weightI~I 
or vehicle. for 3 days before surg8!Y and again just after complet-
ing hepatic resection. The values are the means from at least 15 
rats ::: SO. 'Significantly di1terent from 70% hepatectomized rats 
(P < .05). "Slgnificantly di1terent from 70% hepatectomized rats 
(P < .01) and CyA-treated 70% hepatectomized rats (P < .(5). 
stimulatory and antiatrophic effects of CyA. FK 506. and 
recombinant FKBP. 
HEPATOCYTE CULTURE 
It was previously shown that CyA and FK 506 did not alter 
hepatocyte proliferation at doses in the medium up to 400 
ngimL. The lack of effect was in standard hepatocyte 
culture or in culture enriched with 10 nglmL epidermal 
growth factor. 7 
In contrast. RPM inhibited hepatocyte proliferation with 
SMALL INTESTINE KIDNEY 
« 
z 
6 a 
6 CII e , 
.., 
4 ~ 
3 e 
0-
2 u 
Nor..... "".,"cle FIC 508 RPM No' ..... Ve"tele FtC SOl RPM 
Fig 2. [3H]thymidine incorporation in normaf and nephrecton1lZed 
(right) and in the normal and 40"10 small intestine reS8CIion (left) 
rats treated or not treated with RPM or FK 506. The animalS 
received an injection of vehicle or drug solutiOn as described in Fig 
1. The values reported ant the means from 5 rats ::: SO. 'Signif-
icantly di1terent from thymidine incorporation in kidneys from 
untreated. operated IIJ'IimalS (P < .05). 
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FIg 3. [3H]thymidine incorporation and percentage of labeled 
hepatoCyte nuclei 24 hours after 70"10 hepatectomy in nude 
(NIH-RNU) rats treated (right) or not treated (left) with FK 506. The 
aninaIs received an injection of vehicle or drug solution as 
described in Fig 1. Mean :: SEM (' P < .05 or ., P < .01 versus 
untreated animals). Ten animals in each group. 
both of the foregoing culture media conditions (Fig 6) with 
a dose/effect relationship (doses and other data given in 
ref. 14). 
RPM EFFECT ON GENE EXPRESSION 
The mRNA of the growth inhibitory factor TGF-I3. was 
determined in the liver of normal. nonoperated rats treated 
for I. 2. 3. or 4 days with 0.3 mg/kg per day RPM. and in 
the liver fragment after 70% PH in rats pretreated before 
PH for 4 days with the same dose of RPM. I. In both 
conditions. unexpected results were obtained with a strik-
ing decrease of the TGF-13 mRNA (Fig 7). The specificity 
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Fig 4. [3HJthymidine incorporabon and percentage of mitOSIs In 
70% hepatectomIZed rats not treated or treated With RPM at 
different doses. Control and immunosuppreSSIVe drug-treated an· 
imals were grven Intramuscular injecllons of vehicte and RPM. 
respectJvely. for 3 days before surg8!Y. and agaan lust after 
com~etillg hepatic resection. The values represented by the barS 
are the means from at least 10 rats :!: SO. 'Significantly dr1lerent 
from 70% hepatectomIZed untreated rats (P < .05). "Slgtvficantly 
difhnnt from 70% hepatectomIZed untreated rats (P < .01). 
RPM INHIBITS HEPATOCYTE PROLIFERATION 
Fig 5. Surgical model of Eck-Fistula (portacaval shunt) with 
external continuous Infusion of FK 506 on other drugs. 12 
of this effect was demonstrated by the complete preserva-
tion of albumin mRNA and glyceraldehyde-3-phosphate 
(gap) mRNA which are nongrowth genes. 
These results and other evidence l4 have shown the 
intrinsically noncytotoxic natu~ of the RPM effect, and its 
specificity to at least one growth control gene. 
DISCUSSION 
This body of work shows that CyA and FK 506 have 
powerful growth promotional and trophic (hepatotrophic) 
effects on intact livers. These qualities of Cy A and FK 506 
cannot be demonstrated in hepatocyte culture. They con-
trast sharply with the growth effects of RPM, which a~ 
anuproliferauve and easily demonstrated in cultu~d hepa-
tocytes. The discovery that RPM has an opposite effect of 
FK 506 is particularly inte~stingK because these two drugs 
are related chemically. and have the same cytosolic bind-
ing sites (FKBP). 
pch~iber and Crabtree have reponed at this symposium 
that these drugs (panicularly FK 5(6) are "prodrugs" 
which may be inert by themselves, but which fonn biolog-
ically active complexes with their binding proteins. By this 
hypothesis, the complexes then act immunologically 
Tible 3. Hepetocyte ProflfMltlon ActIvtty After FK 501 infusion 
Into the Lett PolUl Vein of Eck-Flatu18 0.. 
FK 506 InfuSIOn P8ICII1I Labeled ~ 
Ra .. (lTIgIkg 
Group per ClaVI Right Lobe Left Lobe PVIIue 
1 o (controls) 4.42 4.45 NS' 
2 0.01 4.n 5.43 .0247 
3 0.1 5.14 5.98 .0886 
4 5.37 9.13 .0510 
'Data 110m ..... 12. 
'NS • IIOnIIQnIfIcMl 
2819 
Table 4. Ellect of Recombinant FKBP Infusion in Lett Portal Branch 
for .. Days Atter Canine ECK Fistula' 
FKBPOose P __ Labeled Hepatocytes 
(ngIkg per 
Grouo day) Right Lobe Left Lobe PValue 
1 a 3.9 3.9 NS 
2 200 4.0 5.0 NS 
3 500 3.9 5.8 05 
4 750 4.0 6.7 .01 
5 1000 4.1 8.2 .005 
'Oata from ref. 13. 
NS • nonsignificant. 
through another (target) molecule tentatively identified by 
pch~iber as calcineurin phosphatase. 
Funher speculation about mechanisms is not warranted 
at this time. However. the possibility is a real one that the 
alterations in signal transduction that are thought to be the 
molecular basis for the immunologic actions of CyA. FK 
506. and RPM may also subserve the growth effects of 
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Fig 6. Ellect of dillerent doses of RPM on DNA synthesis in 
hepatocytes cultured in Ihe presence (upper) or not (lower) of 
epidennal growth factor (EGF). Hepatocytes were Isolated and 
plaled al a density of 1.5 x loa cell/dish In 1.5 mL of minimum 
essential medium (MEM) + 5% fetal calf serum + insulin (10- 7 
moIIL). and maintained a137"C In a 5% co2 atmosphere. FollOWing 
a 3-hour attact'lmenl penod. the medium was substituted With 1.5 
mL of fresh MEM and Insulin with or without EGF (10 mglmL). 
DNA content. (3H}thymldtne incorporation. and labeled nuclei were 
determmed as described/· I • When added to the incubation me-
dium. RPM was used at concentrations as repofted in the figure. 
which did not alleet hepatocyte viability (data nol shown!. The 
values reponed represenllhe means of 10 expellments = SO. 
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1 2 
• b c d • f FIg 7. Northern gel of TGFB1 
mRNA. albumin mRNA. and Gap 
mRNA levels from livers of rest· 
ing rats (frames 1 to 3) treated 
with RPM (c = for 1 day, d = for 
2 days. e = for 3 days, and I = 
lor 4 days) and not treated with 
RPM (a. b). Frame .. shows the 
Northern gel of TGFB1 mRNA 
levels lrom livers after partial 
hepatectomy (48 hours) treated 
without (a, or with (b) RPM. Lane 
c is RNA from nonparenchymal 
liver celis (positive control). The 
daily dose of RPM was 0.3 mglkg 
1M (data from ref. 14). 
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these drugs by similar alteration of signal transduction and 
consequent specific changes of gene expression. 
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